Antifungal drug susceptibility testing.

[1]  N. Russell,et al.  Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[2]  J. Galgiani,et al.  Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods , 1987, Antimicrobial Agents and Chemotherapy.

[3]  P. Hoeprich,et al.  Effect of buffers on testing of Candida species susceptibility to flucytosine , 1987, Journal of clinical microbiology.

[4]  R. L. Bennett,et al.  Broth dilution testing of Candida albicans susceptibility to ketoconazole , 1987, Antimicrobial Agents and Chemotherapy.

[5]  K. Chapin,et al.  Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts , 1986, Journal of clinical microbiology.

[6]  M. Radetsky,et al.  Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome , 1986, Journal of clinical microbiology.

[7]  Hughes Ce,et al.  Role of pH in the lethal direct cell damaging action of miconazole. , 1986 .

[8]  J. Galgiani,et al.  Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo , 1986, Antimicrobial Agents and Chemotherapy.

[9]  N. Russell,et al.  The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. , 1986, Journal of general microbiology.

[10]  P. Hoeprich,et al.  Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole , 1986, Journal of clinical microbiology.

[11]  F. Odds,et al.  Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions. , 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[12]  J. Galgiani,et al.  Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B , 1986, Journal of clinical microbiology.

[13]  D. Kerridge.  Mode of action of clinically important antifungal drugs. , 1986, Advances in microbial physiology.

[14]  W. Dismukes,et al.  Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole. , 1985, The Journal of infectious diseases.

[15]  P. Troke,et al.  Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes , 1985, Antimicrobial Agents and Chemotherapy.

[16]  H. Bossche.  Biochemical Targets for Antifungal Azole Derivatives: Hypothesis on the Mode of Action , 1985 .

[17]  F. Odds,et al.  Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model. , 1985, Chemotherapy.

[18]  D. Kerridge,et al.  Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans , 1984, Antimicrobial Agents and Chemotherapy.

[19]  J. V. van Cutsem,et al.  Itraconazole, a new triazole that is orally active in aspergillosis , 1984, Antimicrobial Agents and Chemotherapy.

[20]  J. Galgiani,et al.  Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media , 1984, Antimicrobial Agents and Chemotherapy.

[21]  F. Odds,et al.  Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents. , 1984, The Journal of antimicrobial chemotherapy.

[22]  R. Hay,et al.  Laboratory methods for flucytosine (5-fluorocytosine) , 1984 .

[23]  J. Heeres,et al.  Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. , 1984, Journal of medicinal chemistry.

[24]  E. Johnson,et al.  In-vitro resistance to imidazole antifungals in Candida albicans. , 1984, The Journal of antimicrobial chemotherapy.

[25]  P. Hoeprich,et al.  In vitro activities of two new antifungal azoles , 1984, Antimicrobial Agents and Chemotherapy.

[26]  M. Plempel.  Versuche zur Korrelation von In‐vitro‐ und In‐vivo‐Wirkungen bei Azol‐Antimykotika , 1984 .

[27]  A. Polak,et al.  Resistance to Systemic Antifungal Agents , 1984 .

[28]  R. Griffith.  Vancomycin use--an historical review. , 1984, The Journal of antimicrobial chemotherapy.

[29]  F. Odds,et al.  Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro. , 1984, The Journal of antimicrobial chemotherapy.

[30]  J. F. Ryley,et al.  Azole resistance in Candida albicans. , 1984, Sabouraudia.

[31]  E. Johnson,et al.  Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans. , 1983, The Journal of antimicrobial chemotherapy.

[32]  R. Fromtling,et al.  In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139. , 1983, Sabouraudia.

[33]  D. Stevens,et al.  Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. , 1983, The Journal of infectious diseases.

[34]  E. Johnson,et al.  MODIFIED RESPONSE TO KETOCONAZOLE OF CANDIDA ALBICANS FROM A TREATMENT FAILURE , 1983, The Lancet.

[35]  H. Yamaguchi,et al.  In-vitro studies of a new oral azole antimycotic, BAY N 7133. , 1983, The Journal of antimicrobial chemotherapy.

[36]  J. Cutsem.  The antifungal activity of ketoconazole , 1983 .

[37]  C. Kirkpatrick,et al.  Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. , 1983, The American journal of medicine.

[38]  N. Nakamizo,et al.  Effects of pH on the Activity of Ketoconazole Against Candida albicans , 1983, Antimicrobial Agents and Chemotherapy.

[39]  M. Plempel,et al.  Antimycotic efficacy of bifonazole in vitro and in vivo. , 1983, Arzneimittel-Forschung.

[40]  R. C. Burchell,et al.  Some considerations for implementing collaborative practice. , 1983, The American journal of medicine.

[41]  F. Odds.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro , 1982, Antimicrobial Agents and Chemotherapy.

[42]  S. Shadomy,et al.  A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro. , 1982, Sabouraudia.

[43]  Beggs Wh.  Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans. , 1982 .

[44]  D. Stevens,et al.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States , 1982, Antimicrobial Agents and Chemotherapy.

[45]  J. Church,et al.  RESISTANCE TO KETOCONAZOLE , 1982, The Lancet.

[46]  M. Plempel.  On the action kinetics of clotrimazole. , 1982, Chemotherapy.

[47]  J. F. Ryley,et al.  Experimental approaches to antifungal chemotherapy. , 1981, Advances in pharmacology and chemotherapy.

[48]  F. Odds.  Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance. , 1980, The Journal of antimicrobial chemotherapy.

[49]  W. Merz,et al.  Incidence of polyene-resistant yeasts recovered from clinical specimens , 1980, Antimicrobial Agents and Chemotherapy.

[50]  T. Granade,et al.  Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum , 1980, Antimicrobial Agents and Chemotherapy.

[51]  M. De Brabander,et al.  Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. , 1979, Postgraduate medical journal.

[52]  I. Haller.  Modern aspects of testing azole antifungals. , 1979, Postgraduate medical journal.

[53]  F. Odds.  Problems in the laboratory assessment of antifungal activity. , 1979, Postgraduate medical journal.

[54]  D. Pappagianis,et al.  Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human , 1979, Antimicrobial Agents and Chemotherapy.

[55]  D. Stevens,et al.  Variability of Agar Dilution-Replicator Method of Yeast Susceptibility Testing , 1979, Antimicrobial Agents and Chemotherapy.

[56]  G. Sandford,et al.  Isolation and characterization of a polyene-resistant variant of Candida tropicalis , 1979, Journal of clinical microbiology.

[57]  J. Joly,et al.  A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine. , 1979, The Journal of infectious diseases.

[58]  D. Stevens.  Drugs for systemic fungal infections. , 1979, Rational drug therapy.

[59]  M. Leeming,et al.  Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative , 1979, Antimicrobial Agents and Chemotherapy.

[60]  P. Hoeprich,et al.  Disk Agar Diffusion Susceptibility Testing of Yeasts , 1978, Antimicrobial Agents and Chemotherapy.

[61]  R. Lehrer,et al.  Development of amphotericin B‐resistant Candida tropicalis in a patient with defective leukocyte function , 1978, The American journal of the medical sciences.

[62]  R. J. Holt,et al.  The emergence of Candida albicans resistant to miconazole during the treatment of urinary tract candidosis. , 1978, Infection.

[63]  J. Galgiani,et al.  Turbidimetric Studies of Growth Inhibition of Yeasts with Three Drugs: Inquiry into Inoculum-Dependent Susceptibility Testing, Time of Onset of Drug Effect, and Implications for Current and Newer Methods , 1978, Antimicrobial Agents and Chemotherapy.

[64]  A. Oehlschlager,et al.  Lipid composition and polyene antibiotic resistance of Candida albicans mutants. , 1978, Canadian journal of biochemistry.

[65]  R. White,et al.  Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B. , 1978, Journal of general microbiology.

[66]  R. Holt,et al.  MICONAZOLE-RESISTANT CANDIDA , 1978, The Lancet.

[67]  P. Hoeprich,et al.  Stability of four antifungal antimicrobics in vitro. , 1978, The Journal of infectious diseases.

[68]  D. Hantschke.  In vitro sensitivity tests with antimycotic imidazole derivatives and evaluation of results. , 1978, Mykosen. Supplement.

[69]  K. Holmberg.  Laboratory tests of antifungal drugs in treatment of systemic mycoses. , 1978, Scandinavian journal of infectious diseases. Supplementum.

[70]  Ng Mh,et al.  The occurrence of Candida in hospital patients and normal subjects. , 1977 .

[71]  S. Shadomy,et al.  Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing. , 1977, The Journal of infectious diseases.

[72]  S. Safe,et al.  Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis. , 1977, Canadian journal of microbiology.

[73]  P. Hoeprich,et al.  Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. , 1976, The Journal of infectious diseases.

[74]  J. Galgiani,et al.  Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum Size , 1976, Antimicrobial Agents and Chemotherapy.

[75]  F. Kayser,et al.  Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis. , 1976, Chemotherapy.

[76]  D. Schlessinger,et al.  Stability of Amphotericin B in Fungal Culture Media , 1975, Antimicrobial Agents and Chemotherapy.

[77]  R. Holt.  Laboratory tests of antifungal drugs. , 1975, Journal of clinical pathology.

[78]  P. Hoeprich,et al.  Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. , 1975, The Journal of infectious diseases.

[79]  A. Espinel-Ingroff,et al.  New Method for Susceptibility Testing with Antifungal Agents , 1975, Antimicrobial Agents and Chemotherapy.

[80]  S. Montplaisir,et al.  Sensibilité et résistance des levures pathogènes aux 5-fluoropyrimidines. I.--Relation entre les phénotypes de résistance a la 5-fluorocytosine, le sérotype de Candida albicans et l'écologie de différentes espèces de Candida d'origine humaine , 1975 .

[81]  A. Polak,et al.  Mode of action of 5-fluorocytosine and mechanisms of resistance. , 1975, Chemotherapy.

[82]  M. Plempel,et al.  Antimycotic properties of clotrimazole. , 1974, Postgraduate medical journal.

[83]  D. Schlessinger,et al.  Molecular Basis for the Selective Toxicity of Amphotericin B for Yeast and Filipin for Animal Cells , 1974, Antimicrobial Agents and Chemotherapy.

[84]  M. Bard,et al.  Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria. , 1974, The Journal of infectious diseases.

[85]  E. Block,et al.  Variables Influencing Susceptibility Testing of Cryptococcus neoformans to 5-Fluorocytosine , 1973, Antimicrobial Agents and Chemotherapy.

[86]  S. Shadomy,et al.  In Vitro Activity of 5-Fluorocytosine Against Candida and Torulopsis Species , 1973, Antimicrobial Agents and Chemotherapy.

[87]  P. Hoeprich,et al.  Obfuscation of the activity of antifungal antimicrobics by culture media. , 1972, The Journal of infectious diseases.

[88]  J. V. van Cutsem,et al.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. , 1972, Chemotherapy.

[89]  H. I. Winner,et al.  The development of resistance by candida species to polyene antibiotics in vitro. , 1971, Journal of medical microbiology.

[90]  J. Sherris,et al.  Antibiotic sensitivity testing. Report of an international collaborative study. , 1971, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[91]  E. Drouhet.  Basic mechanisms of antifungal chemotherapy. , 1970, Modern treatment.

[92]  D. Watkin,et al.  ARTERITIS OF THE AORTA AND ITS BRANCHES. , 1965, Lancet.

[93]  G. Baum,et al.  In vitro susceptibility of 24 strains of Histoplasma capsulatum to amphotericin B. , 1961, Antibiotics & chemotherapy.